Henan Grand Biopharmaceutical

Henan Grand Biopharmaceutical is a China-based biopharmaceutical company focused on human vaccines and related biologics. Available public sources indicate the company is a subsidiary within the Grand Pharma ecosystem and is primarily associated with a commercialized rabies vaccine made using hamster kidney cells for the Chinese market. The company appears to have a relatively narrow disclosed pipeline centered on infectious disease prevention rather than a broad innovative drug portfolio. Public English-language information is limited, but the company is identifiable as an active healthcare manufacturer rather than a non-operating shell. It should be viewed mainly as a regional vaccine producer with legacy commercial rabies-vaccine assets.